Marie L De Bruin
Marie L De Bruin
Assistant Professor, Utrecht University
Verified email at
Cited by
Cited by
Prolonged QTc interval and risk of sudden cardiac death in a population of older adults
SMJM Straus, JA Kors, ML De Bruin, CS van der Hooft, A Hofman, ...
Journal of the American College of Cardiology 47 (2), 362-367, 2006
Late cardiotoxicity after treatment for Hodgkin lymphoma
BMP Aleman, AW van den Belt-Dusebout, ML De Bruin, MB van't Veer, ...
Blood 109 (5), 1878-1886, 2007
Late cardiotoxicity after treatment for Hodgkin lymphoma
BMP Aleman, AW van den Belt-Dusebout, ML De Bruin, MB van't Veer, ...
Blood 109 (5), 1878-1886, 2007
170: Late Cardiotoxicity after Treatment for Hodgkin’s Lymphoma
BMP Aleman, AW van den Belt-Dusebout, ML De Bruin, MB van’t Veer, ...
International Journal of Radiation Oncology* Biology* Physics 66 (3), S96, 2006
Perinatal morbidity and mortality in early‐onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)
C Lees, N Marlow, B Arabin, CM Bilardo, C Brezinka, JB Derks, J Duvekot, ...
Ultrasound in obstetrics & gynecology 42 (4), 400-408, 2013
Epidemiology of adverse drug reactions in Europe: a review of recent observational studies
JC Bouvy, ML De Bruin, MA Koopmanschap
Drug safety 38, 437-453, 2015
Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes
ML De Bruin, J Sparidans, MB van't Veer, EM Noordijk, MWJ Louwman, ...
Journal of Clinical oncology 27 (26), 4239-4246, 2009
Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death
ML De Bruin, M Pettersson, RHB Meyboom, AW Hoes, HGM Leufkens
European heart journal 26 (6), 590-597, 2005
Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma
ML De Bruin, LDA Dorresteijn, MB van't Veer, ADG Krol, HJ Van der Pal, ...
JNCI: Journal of the National Cancer Institute 101 (13), 928-937, 2009
A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16. 1 (REL), 8q24. 21 and 10p14 (GATA3)
V Enciso-Mora, P Broderick, Y Ma, RF Jarrett, H Hjalgrim, K Hemminki, ...
Nature genetics 42 (12), 1126-1130, 2010
The epidemiology of extra-articular manifestations in ankylosing spondylitis: a population-based matched cohort study
C Stolwijk, I Essers, A van Tubergen, A Boonen, MT Bazelier, ...
Annals of the rheumatic diseases 74 (7), 1373-1378, 2015
Antidepressant prescribing in five European countries: application of common definitions to assess the prevalence, clinical observations, and methodological implications
V Abbing-Karahagopian, C Huerta, PC Souverein, F De Abajo, ...
European journal of clinical pharmacology 70, 849-857, 2014
Treatment-related risk factors for premature menopause following Hodgkin lymphoma
ML De Bruin, J Huisbrink, M Hauptmann, MA Kuenen, GM Ouwens, ...
Blood, The Journal of the American Society of Hematology 111 (1), 101-108, 2008
The risk of colorectal cancer in patients with type 2 diabetes: associations with treatment stage and obesity
PJHL Peeters, MT Bazelier, HGM Leufkens, F de Vries, ML De Bruin
Diabetes Care 38 (3), 495-502, 2015
Glucose-lowering agents and the patterns of risk for cancer: a study with the General Practice Research Database and secondary care data
TP Van Staa, D Patel, AM Gallagher, ML De Bruin
Diabetologia 55, 654-665, 2012
In‐hospital cardiac arrest is associated with use of non‐antiarrhythmic QTc‐prolonging drugs
ML De Bruin, PNJ Langendijk, RP Koopmans, AAM Wilde, HGM Leufkens, ...
British journal of clinical pharmacology 63 (2), 216-223, 2007
Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross‐national descriptive study from the PROTECT‐EU …
C Huerta, V Abbing‐Karahagopian, G Requena, B Oliva, Y Alvarez, ...
Pharmacoepidemiology and drug safety 25, 56-65, 2016
Use of Insulin and Insulin Analogs and Risk of Cancer—Systematic Review and Meta-Analysis of Observational Studies
O Karlstad, J Starup Linde, P Vestergaard, V Hjellvik, M T Bazelier, ...
Current drug safety 8 (5), 333-348, 2013
Roles of radiation dose and chemotherapy in the etiology of stomach cancer as a second malignancy
AW van den Belt-Dusebout, BMP Aleman, G Besseling, ML de Bruin, ...
International Journal of Radiation Oncology* Biology* Physics 75 (5), 1420-1429, 2009
Ankylosing spondylitis and risk of ischaemic heart disease: a population-based cohort study
I Essers, C Stolwijk, A Boonen, ML De Bruin, MT Bazelier, F de Vries, ...
Annals of the rheumatic diseases 75 (1), 203-209, 2016
The system can't perform the operation now. Try again later.
Articles 1–20